Infectious Diseases
Latest News
U.S. has new dominant COVID variant called EG.5
Called “Eris” among avid COVID trackers, the strain EG.5 now accounts for 17% of all U.S. COVID infections.
From the Journals
Early-life antibiotic use may raise risk of early-onset CRC
"Individuals with genetic risk factors (i.e., family history of CRC) who have experienced early-life antibiotics use on a long-term basis are...
Conference Coverage
Offering HPV vaccine at age 9 linked to greater series completion
Despite recommendations to bundle HPV vaccine administration with that of Tdap and meningococcal vaccines, offering it sooner increases the...
Latest News
Does screening kids with acute sinusitis symptoms for bacterial infection cut unnecessary antibiotic use?
If antibiotic use was limited to children with H. influenzae or S. pneumoniae in their nasopharynx at the time of diagnosis, antibiotic use would...
Latest News
Partial immunization leaves children and communities at risk, study finds
The strongest association with not completing the vaccine series was moving across state lines and not having insurance.
Latest News
FDA approves cantharidin for molluscum contagiosum
The development marks the first FDA-approved treatment for the condition.
Latest News
Case report describes pediatric RIME triggered by norovirus
The study author says the incidence of RIME appears to be increasing, although its true epidemiology is unknown.
Conference Coverage
Infection-related chronic illness: A new paradigm for research and treatment
Researchers are looking to build a common research agenda for infection-related chronic illnesses to “understand the epidemiology and pathogenesis...
Conference Coverage
Research points toward combination therapy for Lyme and improved diagnostics
Lyme disease researchers are investigating combination therapy to address “persister” bacteria and diagnostic tests that test directly for the...
ID Consult
Summer diarrhea – Time to think outside the box
While not an everyday diagnosis, waterborne parasites need to be in our summertime diarrheal differentials.
News from the FDA/CDC
FDA approves RSV monoclonal antibody for all infants
The long-acting antibody is given as a single intramuscular injection.